BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22228907)

  • 1. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
    Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
    J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
    Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
    Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
    Hoorens A; Prenzel K; Lemoine NR; Klöppel G
    J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
    Tobita K; Kijima H; Chino O; Dowaki S; Kashiwagi H; Tanaka M; Ohtani Y; Inokuchi S; Makuuchi H
    Anticancer Res; 2001; 21(3C):2131-4. PubMed ID: 11501836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging and pathological characteristics of small acinar cell carcinomas of the pancreas: A report of 3 cases.
    Matsumoto S; Sata N; Koizumi M; Lefor A; Yasuda Y
    Pancreatology; 2013; 13(3):320-3. PubMed ID: 23719608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior?
    Machado MC; Machado MA; Perini MV; Herman P; Jukemura J; Leite KR; Bacchella T
    Hepatogastroenterology; 2008; 55(82-83):708-10. PubMed ID: 18613439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
    La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
    Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cercariform cells: another cytologic feature distinguishing solid pseudopapillary neoplasms from pancreatic endocrine neoplasms and acinar cell carcinomas in endoscopic ultrasound-guided fine-needle aspirates.
    Samad A; Shah AA; Stelow EB; Alsharif M; Cameron SE; Pambuccian SE
    Cancer Cytopathol; 2013 Jun; 121(6):298-310. PubMed ID: 23765692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.
    Kim JY; Brosnan-Cashman JA; Kim J; An S; Lee KB; Kim H; Park DY; Jang KT; Oh YH; Hruban RH; Heaphy CM; Hong SM
    Pathology; 2020 Apr; 52(3):336-347. PubMed ID: 32111396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinar cell carcinoma of the pancreas. A histologic, immunocytochemical and ultrastructural study.
    Caruso RA; Inferrera A; Tuccari G; Barresi G
    Histol Histopathol; 1994 Jan; 9(1):53-8. PubMed ID: 8003821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma.
    Ohike N; Kosmahl M; Klöppel G
    Virchows Arch; 2004 Sep; 445(3):231-5. PubMed ID: 15517367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
    Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y; Xie J; Wang B; Mu Y; Liu P
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
    Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
    Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous fat necrosis as the presenting feature of a pancreatic carcinoma: the challenge of differentiating endocrine and acinar pancreatic neoplasms.
    Martin SK; Agarwal G; Lynch GR
    Pancreas; 2009 Mar; 38(2):219-22. PubMed ID: 19238022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinar cell carcinoma with prominent intraductal growth pattern: case report and review of the literature.
    Toll AD; Mitchell D; Yeo CJ; Hruban RH; Witkiewicz AK
    Int J Surg Pathol; 2011 Dec; 19(6):795-9. PubMed ID: 19584100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of pancreatic acinar differentiation in gastric adenocarcinoma: report of a case and immunohistochemical study of 111 additional cases.
    Lee H; Tang LH; Veras EF; Klimstra DS
    Am J Surg Pathol; 2012 Mar; 36(3):402-8. PubMed ID: 22082608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of L1 in pancreatic masses distinguishes adenocarcinomas from poorly differentiated neuroendocrine carcinomas.
    Kaifi JT; Heidtmann S; Schurr PG; Reichelt U; Mann O; Yekebas EF; Wachowiak R; Strate T; Schachner M; Izbicki JR
    Anticancer Res; 2006; 26(2A):1167-70. PubMed ID: 16619519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.